ahlam1399
04-08-2016, 03:05 AM
FDA approves Abiomed?s device to treat cardiac shocks
(Reuters) - The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading.
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2.img (http://da.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/ach.img (http://adchoice.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/ach.htm)http://pi.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2t.imghttp://pi2.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4ecbb3be/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NC3yQTW1AOk:BxUk1vPweqc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NC3yQTW1AOk:BxUk1vPweqc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/NC3yQTW1AOk
(Reuters) - The U.S Food and Drug Administration approved Abiomed Inc's heart pump to treat patients who suffer cardiac shock after heart attack or heart surgery, sending its shares up about 4 percent in extended trading.
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2.img (http://da.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/ach.img (http://adchoice.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/ach.htm)http://pi.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2t.imghttp://pi2.feedsportal.com/r/257412676258/u/49/f/654207/c/35217/s/4ecbb3be/sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4ecbb3be/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NC3yQTW1AOk:BxUk1vPweqc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=NC3yQTW1AOk:BxUk1vPweqc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=NC3yQTW1AOk:BxUk1vPweqc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/NC3yQTW1AOk